EC Healthcare

SHSC:2138 Stock Report

Market Cap: HK$900.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

EC Healthcare Future Growth

Future criteria checks 4/6

EC Healthcare is forecast to grow earnings and revenue by 97.7% and 11.5% per annum respectively. EPS is expected to grow by 97.6% per annum. Return on equity is forecast to be 11.8% in 3 years.

Key information

97.7%

Earnings growth rate

97.6%

EPS growth rate

Consumer Services earnings growth21.0%
Revenue growth rate11.5%
Future return on equity11.8%
Analyst coverage

Low

Last updated26 Jul 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:2138 - Analysts future estimates and past financials data (HKD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20265,289237N/A1,1701
3/31/20254,806159N/A9902
3/31/20244,211-19528689N/A
12/31/20234,157-11422709N/A
9/30/20234,104-4317729N/A
6/30/20233,98933255667N/A
3/31/20233,87570193605N/A
12/31/20223,62293162499N/A
9/30/20223,369117132392N/A
6/30/20223,144157240500N/A
3/31/20222,920198348608N/A
12/31/20212,823253479684N/A
9/30/20212,727309610760N/A
6/30/20212,404251541690N/A
3/31/20212,080193472621N/A
12/31/20201,854163487597N/A
9/30/20201,627133503573N/A
6/30/20201,788210505574N/A
3/31/20201,949287507576N/A
12/31/20192,023325273452N/A
9/30/20192,09836440327N/A
6/30/20191,975363-5283N/A
3/31/20191,852361-49238N/A
12/31/20181,715355108278N/A
9/30/20181,578348265317N/A
6/30/20181,450314269320N/A
3/31/20181,322279272324N/A
12/31/20171,253266N/A302N/A
9/30/20171,183253N/A280N/A
6/30/20171,079227N/A230N/A
3/31/2017975201N/A180N/A
12/31/2016878170N/A123N/A
9/30/2016780139N/A66N/A
6/30/2016744144N/A71N/A
3/31/2016708149N/A76N/A
12/31/2015688166N/A105N/A
9/30/2015668183N/A134N/A
6/30/2015645179N/A146N/A
3/31/2015621174N/A159N/A
3/31/201449081N/A145N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2138 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: 2138 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 2138 is expected to become profitable in the next 3 years.

Revenue vs Market: 2138's revenue (11.5% per year) is forecast to grow faster than the Hong Kong market (7.3% per year).

High Growth Revenue: 2138's revenue (11.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2138's Return on Equity is forecast to be low in 3 years time (11.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y